InfuSystem Holdings, Inc (INFU) stock
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/302% above fair value
$14.67−0.12 (-0.81%)
Close on Nov 18, 2026Market cap $292.19MP/E 35.8Yield –
InfuSystem revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
InfuSystem's revenue for the twelve months ending Jun 30, 2026 was $143.34M, up 2.5% year over year. For fiscal 2025 it was $143.44M, up 6.4% from the year before. Over ten years it grew 7.4% a year on average. The highest annual figure on record is $143.44M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $143.44M | +6.4% |
| FY2024 | Dec 31, 2024 | $134.86M | +7.2% |
| FY2023 | Dec 31, 2023 | $125.79M | +14.4% |
| FY2022 | Dec 31, 2022 | $109.91M | +7.4% |
| FY2021 | Dec 31, 2021 | $102.38M | +5.1% |
| FY2020 | Dec 31, 2020 | $97.39M | +20.1% |
| FY2019 | Dec 31, 2019 | $81.12M | +20.8% |
| FY2018 | Dec 31, 2018 | $67.14M | -5.5% |
| FY2017 | Dec 31, 2017 | $71.08M | +0.8% |
| FY2016 | Dec 31, 2016 | $70.50M | -0.1% |
| FY2015 | Dec 31, 2015 | $70.54M | +6.1% |
| FY2014 | Dec 31, 2014 | $66.49M | +6.8% |
| FY2013 | Dec 31, 2013 | $62.28M | +5.9% |
| FY2012 | Dec 31, 2012 | $58.83M | +7.7% |
| FY2011 | Dec 31, 2011 | $54.64M | +15.7% |
| FY2010 | Dec 31, 2010 | $47.23M | +21.2% |
| FY2009 | Dec 31, 2009 | $38.96M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $36.93M | +2.6% |
| Q1 FY2026 | Mar 31, 2026 | $33.68M | -3.0% |
| Q4 FY2025 | Dec 31, 2025 | $36.23M | +7.0% |
| Q3 FY2025 | Sep 30, 2025 | $36.49M | +3.3% |
| Q2 FY2025 | Jun 30, 2025 | $36.00M | +6.8% |
| Q1 FY2025 | Mar 31, 2025 | $34.72M | +8.5% |
| Q4 FY2024 | Dec 31, 2024 | $33.85M | +6.5% |
| Q3 FY2024 | Sep 30, 2024 | $35.32M | +10.7% |
| Q2 FY2024 | Jun 30, 2024 | $33.70M | +6.2% |
| Q1 FY2024 | Mar 31, 2024 | $32.00M | +5.4% |
| Q4 FY2023 | Dec 31, 2023 | $31.77M | +10.2% |
| Q3 FY2023 | Sep 30, 2023 | $31.91M | +17.0% |
| Q2 FY2023 | Jun 30, 2023 | $31.74M | +17.4% |
| Q1 FY2023 | Mar 31, 2023 | $30.37M | +13.5% |
| Q4 FY2022 | Dec 31, 2022 | $28.83M | +8.7% |
| Q3 FY2022 | Sep 30, 2022 | $27.28M | +2.7% |
| Q2 FY2022 | Jun 30, 2022 | $27.04M | +8.9% |
| Q1 FY2022 | Mar 31, 2022 | $26.76M | +9.4% |
| Q4 FY2021 | Dec 31, 2021 | $26.52M | +7.3% |
| Q3 FY2021 | Sep 30, 2021 | $26.57M | +5.7% |
| Q2 FY2021 | Jun 30, 2021 | $24.83M | -4.5% |
| Q1 FY2021 | Mar 31, 2021 | $24.46M | +13.5% |
| Q4 FY2020 | Dec 31, 2020 | $24.71M | +13.8% |
| Q3 FY2020 | Sep 30, 2020 | $25.13M | +16.9% |
| Q2 FY2020 | Jun 30, 2020 | $26.00M | +31.8% |
| Q1 FY2020 | Mar 31, 2020 | $21.55M | +18.5% |
| Q4 FY2019 | Dec 31, 2019 | $21.71M | +23.6% |
| Q3 FY2019 | Sep 30, 2019 | $21.49M | +28.9% |
| Q2 FY2019 | Jun 30, 2019 | $19.72M | +20.2% |
| Q1 FY2019 | Mar 31, 2019 | $18.19M | +10.4% |
| Q4 FY2018 | Dec 31, 2018 | $17.56M | -7.0% |
| Q3 FY2018 | Sep 30, 2018 | $16.68M | -5.2% |
| Q2 FY2018 | Jun 30, 2018 | $16.42M | -3.1% |
| Q1 FY2018 | Mar 31, 2018 | $16.48M | -6.6% |
| Q4 FY2017 | Dec 31, 2017 | $18.89M | +12.1% |
| Q3 FY2017 | Sep 30, 2017 | $17.59M | +2.1% |
| Q2 FY2017 | Jun 30, 2017 | $16.94M | – |
| Q1 FY2017 | Mar 31, 2017 | $17.65M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.85M | – |
| Q3 FY2016 | Sep 30, 2016 | $17.23M | – |
See a number that looks wrong?